nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—ABCB1—melanoma	0.426	1	CbGaD
Loratadine—CYP3A4—Temozolomide—melanoma	0.114	0.284	CbGbCtD
Loratadine—CYP2D6—Vemurafenib—melanoma	0.0983	0.245	CbGbCtD
Loratadine—ABCB1—Dactinomycin—melanoma	0.0693	0.173	CbGbCtD
Loratadine—CYP3A4—Vemurafenib—melanoma	0.0625	0.156	CbGbCtD
Loratadine—ABCB1—Docetaxel—melanoma	0.0358	0.0892	CbGbCtD
Loratadine—CYP3A4—Docetaxel—melanoma	0.0214	0.0534	CbGbCtD
Loratadine—Drug interaction—Carmustine—melanoma	0.00214	0.0169	CcSEcCtD
Loratadine—Viral infection—Temozolomide—melanoma	0.00212	0.0168	CcSEcCtD
Loratadine—Alopecia—Vemurafenib—melanoma	0.00167	0.0132	CcSEcCtD
Loratadine—Dysgeusia—Vemurafenib—melanoma	0.00161	0.0127	CcSEcCtD
Loratadine—Lethargy—Dactinomycin—melanoma	0.00157	0.0124	CcSEcCtD
Loratadine—Cough—Vemurafenib—melanoma	0.00143	0.0113	CcSEcCtD
Loratadine—Myalgia—Vemurafenib—melanoma	0.0014	0.011	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00139	0.011	CcSEcCtD
Loratadine—Drug interaction—Docetaxel—melanoma	0.00138	0.0109	CcSEcCtD
Loratadine—Anaphylactic shock—Vemurafenib—melanoma	0.00134	0.0106	CcSEcCtD
Loratadine—Nervous system disorder—Vemurafenib—melanoma	0.00131	0.0104	CcSEcCtD
Loratadine—Skin disorder—Vemurafenib—melanoma	0.0013	0.0103	CcSEcCtD
Loratadine—Hypotension—Vemurafenib—melanoma	0.00125	0.00989	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00122	0.00965	CcSEcCtD
Loratadine—Gastrointestinal disorder—Vemurafenib—melanoma	0.00116	0.00914	CcSEcCtD
Loratadine—Fatigue—Vemurafenib—melanoma	0.00116	0.00913	CcSEcCtD
Loratadine—Constipation—Vemurafenib—melanoma	0.00115	0.00905	CcSEcCtD
Loratadine—Pollakiuria—Temozolomide—melanoma	0.00111	0.00879	CcSEcCtD
Loratadine—Depression—Carmustine—melanoma	0.00111	0.00875	CcSEcCtD
Loratadine—Depression—Temozolomide—melanoma	0.00107	0.00846	CcSEcCtD
Loratadine—Body temperature increased—Vemurafenib—melanoma	0.00106	0.00837	CcSEcCtD
Loratadine—Pharyngitis—Dactinomycin—melanoma	0.00106	0.00836	CcSEcCtD
Loratadine—Hepatobiliary disease—Temozolomide—melanoma	0.00102	0.00802	CcSEcCtD
Loratadine—Alopecia—Bleomycin—melanoma	0.00101	0.00798	CcSEcCtD
Loratadine—Dermatitis bullous—Docetaxel—melanoma	0.000969	0.00766	CcSEcCtD
Loratadine—Asthenia—Vemurafenib—melanoma	0.000961	0.0076	CcSEcCtD
Loratadine—Pharyngitis—Temozolomide—melanoma	0.000957	0.00756	CcSEcCtD
Loratadine—Lethargy—Docetaxel—melanoma	0.000945	0.00747	CcSEcCtD
Loratadine—Alopecia—Dactinomycin—melanoma	0.000942	0.00744	CcSEcCtD
Loratadine—Ill-defined disorder—Bleomycin—melanoma	0.000923	0.00729	CcSEcCtD
Loratadine—Diarrhoea—Vemurafenib—melanoma	0.000917	0.00724	CcSEcCtD
Loratadine—Tinnitus—Temozolomide—melanoma	0.000899	0.0071	CcSEcCtD
Loratadine—Malaise—Bleomycin—melanoma	0.000897	0.00709	CcSEcCtD
Loratadine—Arrhythmia—Carmustine—melanoma	0.000891	0.00704	CcSEcCtD
Loratadine—Dizziness—Vemurafenib—melanoma	0.000886	0.007	CcSEcCtD
Loratadine—Alopecia—Carmustine—melanoma	0.000881	0.00696	CcSEcCtD
Loratadine—Immune system disorder—Temozolomide—melanoma	0.000871	0.00688	CcSEcCtD
Loratadine—Cough—Bleomycin—melanoma	0.000868	0.00686	CcSEcCtD
Loratadine—Ill-defined disorder—Dactinomycin—melanoma	0.000861	0.0068	CcSEcCtD
Loratadine—Vomiting—Vemurafenib—melanoma	0.000852	0.00673	CcSEcCtD
Loratadine—Alopecia—Temozolomide—melanoma	0.000852	0.00673	CcSEcCtD
Loratadine—Chest pain—Bleomycin—melanoma	0.000847	0.00669	CcSEcCtD
Loratadine—Myalgia—Bleomycin—melanoma	0.000847	0.00669	CcSEcCtD
Loratadine—Abdominal pain upper—Docetaxel—melanoma	0.000846	0.00669	CcSEcCtD
Loratadine—Rash—Vemurafenib—melanoma	0.000845	0.00668	CcSEcCtD
Loratadine—Dermatitis—Vemurafenib—melanoma	0.000844	0.00667	CcSEcCtD
Loratadine—Headache—Vemurafenib—melanoma	0.000839	0.00663	CcSEcCtD
Loratadine—Discomfort—Bleomycin—melanoma	0.000837	0.00661	CcSEcCtD
Loratadine—Malaise—Dactinomycin—melanoma	0.000836	0.00661	CcSEcCtD
Loratadine—Dysgeusia—Temozolomide—melanoma	0.000822	0.00649	CcSEcCtD
Loratadine—Anaphylactic shock—Bleomycin—melanoma	0.000812	0.00641	CcSEcCtD
Loratadine—Agitation—Carmustine—melanoma	0.000798	0.0063	CcSEcCtD
Loratadine—Nausea—Vemurafenib—melanoma	0.000796	0.00629	CcSEcCtD
Loratadine—Myalgia—Dactinomycin—melanoma	0.00079	0.00624	CcSEcCtD
Loratadine—Discomfort—Dactinomycin—melanoma	0.00078	0.00617	CcSEcCtD
Loratadine—Ill-defined disorder—Temozolomide—melanoma	0.000778	0.00615	CcSEcCtD
Loratadine—Agitation—Temozolomide—melanoma	0.000771	0.00609	CcSEcCtD
Loratadine—Angioedema—Temozolomide—melanoma	0.000767	0.00606	CcSEcCtD
Loratadine—Hypotension—Bleomycin—melanoma	0.000758	0.00599	CcSEcCtD
Loratadine—Malaise—Temozolomide—melanoma	0.000757	0.00598	CcSEcCtD
Loratadine—Hypertension—Carmustine—melanoma	0.00075	0.00592	CcSEcCtD
Loratadine—Palpitations—Temozolomide—melanoma	0.000741	0.00586	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Bleomycin—melanoma	0.00074	0.00584	CcSEcCtD
Loratadine—Chest pain—Carmustine—melanoma	0.000739	0.00584	CcSEcCtD
Loratadine—Myalgia—Carmustine—melanoma	0.000739	0.00584	CcSEcCtD
Loratadine—Cough—Temozolomide—melanoma	0.000732	0.00579	CcSEcCtD
Loratadine—Paraesthesia—Bleomycin—melanoma	0.000729	0.00576	CcSEcCtD
Loratadine—Hypertension—Temozolomide—melanoma	0.000724	0.00572	CcSEcCtD
Loratadine—Myalgia—Temozolomide—melanoma	0.000714	0.00564	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000709	0.00561	CcSEcCtD
Loratadine—Discomfort—Temozolomide—melanoma	0.000706	0.00558	CcSEcCtD
Loratadine—Dry mouth—Temozolomide—melanoma	0.000699	0.00552	CcSEcCtD
Loratadine—Pain—Bleomycin—melanoma	0.000694	0.00549	CcSEcCtD
Loratadine—Tachycardia—Carmustine—melanoma	0.000692	0.00546	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00069	0.00545	CcSEcCtD
Loratadine—Anaphylactic shock—Temozolomide—melanoma	0.000685	0.00541	CcSEcCtD
Loratadine—Hepatobiliary disease—Docetaxel—melanoma	0.000675	0.00534	CcSEcCtD
Loratadine—Epistaxis—Docetaxel—melanoma	0.000673	0.00532	CcSEcCtD
Loratadine—Nervous system disorder—Temozolomide—melanoma	0.000671	0.00531	CcSEcCtD
Loratadine—Feeling abnormal—Bleomycin—melanoma	0.000669	0.00529	CcSEcCtD
Loratadine—Skin disorder—Temozolomide—melanoma	0.000665	0.00526	CcSEcCtD
Loratadine—Hypotension—Carmustine—melanoma	0.000662	0.00523	CcSEcCtD
Loratadine—Fatigue—Dactinomycin—melanoma	0.000653	0.00516	CcSEcCtD
Loratadine—Pain—Dactinomycin—melanoma	0.000647	0.00512	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Carmustine—melanoma	0.000646	0.0051	CcSEcCtD
Loratadine—Body temperature increased—Bleomycin—melanoma	0.000642	0.00507	CcSEcCtD
Loratadine—Insomnia—Carmustine—melanoma	0.000641	0.00506	CcSEcCtD
Loratadine—Paraesthesia—Carmustine—melanoma	0.000636	0.00503	CcSEcCtD
Loratadine—Pharyngitis—Docetaxel—melanoma	0.000636	0.00503	CcSEcCtD
Loratadine—Somnolence—Carmustine—melanoma	0.00063	0.00498	CcSEcCtD
Loratadine—Feeling abnormal—Dactinomycin—melanoma	0.000624	0.00493	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000624	0.00493	CcSEcCtD
Loratadine—Insomnia—Temozolomide—melanoma	0.000619	0.00489	CcSEcCtD
Loratadine—Gastrointestinal pain—Dactinomycin—melanoma	0.000619	0.00489	CcSEcCtD
Loratadine—Paraesthesia—Temozolomide—melanoma	0.000615	0.00486	CcSEcCtD
Loratadine—Gastrointestinal disorder—Carmustine—melanoma	0.000612	0.00483	CcSEcCtD
Loratadine—Somnolence—Temozolomide—melanoma	0.000609	0.00481	CcSEcCtD
Loratadine—Constipation—Carmustine—melanoma	0.000606	0.00479	CcSEcCtD
Loratadine—Pain—Carmustine—melanoma	0.000606	0.00479	CcSEcCtD
Loratadine—Dyspepsia—Temozolomide—melanoma	0.000603	0.00476	CcSEcCtD
Loratadine—Abdominal pain—Dactinomycin—melanoma	0.000598	0.00473	CcSEcCtD
Loratadine—Body temperature increased—Dactinomycin—melanoma	0.000598	0.00473	CcSEcCtD
Loratadine—Gastrointestinal disorder—Temozolomide—melanoma	0.000591	0.00467	CcSEcCtD
Loratadine—Fatigue—Temozolomide—melanoma	0.00059	0.00467	CcSEcCtD
Loratadine—Pain—Temozolomide—melanoma	0.000586	0.00463	CcSEcCtD
Loratadine—Constipation—Temozolomide—melanoma	0.000586	0.00463	CcSEcCtD
Loratadine—Feeling abnormal—Carmustine—melanoma	0.000584	0.00461	CcSEcCtD
Loratadine—Asthenia—Bleomycin—melanoma	0.000582	0.0046	CcSEcCtD
Loratadine—Gastrointestinal pain—Carmustine—melanoma	0.000579	0.00458	CcSEcCtD
Loratadine—Immune system disorder—Docetaxel—melanoma	0.000579	0.00457	CcSEcCtD
Loratadine—Arrhythmia—Docetaxel—melanoma	0.000573	0.00452	CcSEcCtD
Loratadine—Alopecia—Docetaxel—melanoma	0.000566	0.00448	CcSEcCtD
Loratadine—Feeling abnormal—Temozolomide—melanoma	0.000564	0.00446	CcSEcCtD
Loratadine—Body temperature increased—Carmustine—melanoma	0.00056	0.00443	CcSEcCtD
Loratadine—Abdominal pain—Carmustine—melanoma	0.00056	0.00443	CcSEcCtD
Loratadine—Gastrointestinal pain—Temozolomide—melanoma	0.00056	0.00442	CcSEcCtD
Loratadine—Dysgeusia—Docetaxel—melanoma	0.000546	0.00432	CcSEcCtD
Loratadine—Asthenia—Dactinomycin—melanoma	0.000543	0.00429	CcSEcCtD
Loratadine—Abdominal pain—Temozolomide—melanoma	0.000541	0.00428	CcSEcCtD
Loratadine—Body temperature increased—Temozolomide—melanoma	0.000541	0.00428	CcSEcCtD
Loratadine—Diarrhoea—Dactinomycin—melanoma	0.000518	0.00409	CcSEcCtD
Loratadine—Vomiting—Bleomycin—melanoma	0.000516	0.00408	CcSEcCtD
Loratadine—Rash—Bleomycin—melanoma	0.000512	0.00404	CcSEcCtD
Loratadine—Dermatitis—Bleomycin—melanoma	0.000511	0.00404	CcSEcCtD
Loratadine—Asthenia—Carmustine—melanoma	0.000508	0.00402	CcSEcCtD
Loratadine—Syncope—Docetaxel—melanoma	0.0005	0.00395	CcSEcCtD
Loratadine—Palpitations—Docetaxel—melanoma	0.000493	0.0039	CcSEcCtD
Loratadine—Asthenia—Temozolomide—melanoma	0.000491	0.00388	CcSEcCtD
Loratadine—Loss of consciousness—Docetaxel—melanoma	0.00049	0.00388	CcSEcCtD
Loratadine—Cough—Docetaxel—melanoma	0.000487	0.00385	CcSEcCtD
Loratadine—Diarrhoea—Carmustine—melanoma	0.000485	0.00383	CcSEcCtD
Loratadine—Nausea—Bleomycin—melanoma	0.000482	0.00381	CcSEcCtD
Loratadine—Hypertension—Docetaxel—melanoma	0.000482	0.00381	CcSEcCtD
Loratadine—Vomiting—Dactinomycin—melanoma	0.000481	0.0038	CcSEcCtD
Loratadine—Rash—Dactinomycin—melanoma	0.000477	0.00377	CcSEcCtD
Loratadine—Chest pain—Docetaxel—melanoma	0.000475	0.00375	CcSEcCtD
Loratadine—Myalgia—Docetaxel—melanoma	0.000475	0.00375	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000472	0.00373	CcSEcCtD
Loratadine—Dizziness—Carmustine—melanoma	0.000469	0.0037	CcSEcCtD
Loratadine—Diarrhoea—Temozolomide—melanoma	0.000468	0.0037	CcSEcCtD
Loratadine—Dry mouth—Docetaxel—melanoma	0.000465	0.00367	CcSEcCtD
Loratadine—Anaphylactic shock—Docetaxel—melanoma	0.000455	0.0036	CcSEcCtD
Loratadine—Dizziness—Temozolomide—melanoma	0.000453	0.00358	CcSEcCtD
Loratadine—Vomiting—Carmustine—melanoma	0.00045	0.00356	CcSEcCtD
Loratadine—Nausea—Dactinomycin—melanoma	0.00045	0.00355	CcSEcCtD
Loratadine—Shock—Docetaxel—melanoma	0.000448	0.00354	CcSEcCtD
Loratadine—Rash—Carmustine—melanoma	0.000447	0.00353	CcSEcCtD
Loratadine—Nervous system disorder—Docetaxel—melanoma	0.000447	0.00353	CcSEcCtD
Loratadine—Dermatitis—Carmustine—melanoma	0.000446	0.00353	CcSEcCtD
Loratadine—Tachycardia—Docetaxel—melanoma	0.000444	0.00351	CcSEcCtD
Loratadine—Headache—Carmustine—melanoma	0.000444	0.00351	CcSEcCtD
Loratadine—Skin disorder—Docetaxel—melanoma	0.000442	0.0035	CcSEcCtD
Loratadine—Vomiting—Temozolomide—melanoma	0.000435	0.00344	CcSEcCtD
Loratadine—Rash—Temozolomide—melanoma	0.000432	0.00341	CcSEcCtD
Loratadine—Dermatitis—Temozolomide—melanoma	0.000431	0.00341	CcSEcCtD
Loratadine—Headache—Temozolomide—melanoma	0.000429	0.00339	CcSEcCtD
Loratadine—Hypotension—Docetaxel—melanoma	0.000425	0.00336	CcSEcCtD
Loratadine—Nausea—Carmustine—melanoma	0.000421	0.00333	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000415	0.00328	CcSEcCtD
Loratadine—Insomnia—Docetaxel—melanoma	0.000412	0.00325	CcSEcCtD
Loratadine—Paraesthesia—Docetaxel—melanoma	0.000409	0.00323	CcSEcCtD
Loratadine—Nausea—Temozolomide—melanoma	0.000407	0.00321	CcSEcCtD
Loratadine—Somnolence—Docetaxel—melanoma	0.000405	0.0032	CcSEcCtD
Loratadine—Dyspepsia—Docetaxel—melanoma	0.000401	0.00317	CcSEcCtD
Loratadine—Gastrointestinal disorder—Docetaxel—melanoma	0.000393	0.00311	CcSEcCtD
Loratadine—Fatigue—Docetaxel—melanoma	0.000393	0.0031	CcSEcCtD
Loratadine—Constipation—Docetaxel—melanoma	0.000389	0.00308	CcSEcCtD
Loratadine—Pain—Docetaxel—melanoma	0.000389	0.00308	CcSEcCtD
Loratadine—Feeling abnormal—Docetaxel—melanoma	0.000375	0.00297	CcSEcCtD
Loratadine—Gastrointestinal pain—Docetaxel—melanoma	0.000372	0.00294	CcSEcCtD
Loratadine—Body temperature increased—Docetaxel—melanoma	0.00036	0.00284	CcSEcCtD
Loratadine—Abdominal pain—Docetaxel—melanoma	0.00036	0.00284	CcSEcCtD
Loratadine—Asthenia—Docetaxel—melanoma	0.000327	0.00258	CcSEcCtD
Loratadine—Diarrhoea—Docetaxel—melanoma	0.000312	0.00246	CcSEcCtD
Loratadine—Dizziness—Docetaxel—melanoma	0.000301	0.00238	CcSEcCtD
Loratadine—Vomiting—Docetaxel—melanoma	0.00029	0.00229	CcSEcCtD
Loratadine—Rash—Docetaxel—melanoma	0.000287	0.00227	CcSEcCtD
Loratadine—Dermatitis—Docetaxel—melanoma	0.000287	0.00227	CcSEcCtD
Loratadine—Headache—Docetaxel—melanoma	0.000285	0.00225	CcSEcCtD
Loratadine—Nausea—Docetaxel—melanoma	0.00027	0.00214	CcSEcCtD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.47e-05	0.000317	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PTK2B—melanoma	1.47e-05	0.000316	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.43e-05	0.000308	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—GAB2—melanoma	1.43e-05	0.000308	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—GNA11—melanoma	1.43e-05	0.000308	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FLT1—melanoma	1.42e-05	0.000306	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PLA2G6—melanoma	1.42e-05	0.000306	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.42e-05	0.000305	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—PIK3CG—melanoma	1.41e-05	0.000304	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PLA2G6—melanoma	1.4e-05	0.000303	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SLC6A11—melanoma	1.39e-05	0.000301	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIP4K2A—melanoma	1.39e-05	0.000301	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—VCAN—melanoma	1.38e-05	0.000298	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.38e-05	0.000298	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—MTAP—melanoma	1.36e-05	0.000293	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—VCAN—melanoma	1.35e-05	0.000291	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FOXO4—melanoma	1.34e-05	0.000289	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HDAC2—melanoma	1.34e-05	0.000289	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CXCR4—melanoma	1.34e-05	0.000289	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—GNAQ—melanoma	1.33e-05	0.000286	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.31e-05	0.000283	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CYP17A1—melanoma	1.31e-05	0.000282	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.29e-05	0.000278	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PIK3CG—melanoma	1.28e-05	0.000276	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	1.27e-05	0.000275	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—VCAN—melanoma	1.27e-05	0.000275	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.26e-05	0.000273	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—VCAN—melanoma	1.26e-05	0.000272	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SYK—melanoma	1.25e-05	0.000269	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—PIK3CD—melanoma	1.24e-05	0.000267	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GNA11—melanoma	1.23e-05	0.000266	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—AKT3—melanoma	1.22e-05	0.000264	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ITGAV—melanoma	1.22e-05	0.000264	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NGFR—melanoma	1.22e-05	0.000264	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—LUM—melanoma	1.21e-05	0.000261	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PHGDH—melanoma	1.21e-05	0.000261	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—FASN—melanoma	1.21e-05	0.000261	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.19e-05	0.000258	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—SLC5A5—melanoma	1.19e-05	0.000256	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HPSE—melanoma	1.19e-05	0.000256	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.17e-05	0.000252	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP17A1—melanoma	1.17e-05	0.000252	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CUBN—melanoma	1.16e-05	0.000251	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.15e-05	0.000249	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.15e-05	0.000248	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GNAQ—melanoma	1.15e-05	0.000248	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CD44—melanoma	1.15e-05	0.000248	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP17A1—melanoma	1.14e-05	0.000246	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	1.14e-05	0.000245	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SOCS1—melanoma	1.13e-05	0.000245	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—MAP2K1—melanoma	1.13e-05	0.000244	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—S100B—melanoma	1.13e-05	0.000244	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CSPG4—melanoma	1.12e-05	0.000243	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—BSG—melanoma	1.12e-05	0.000243	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SDHD—melanoma	1.12e-05	0.000243	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.12e-05	0.000243	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PIK3CD—melanoma	1.12e-05	0.000242	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.11e-05	0.00024	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GNA11—melanoma	1.1e-05	0.000238	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CYP1B1—melanoma	1.1e-05	0.000237	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GPAM—melanoma	1.09e-05	0.000235	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ERBB4—melanoma	1.08e-05	0.000233	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—FASN—melanoma	1.08e-05	0.000233	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—PIK3CB—melanoma	1.08e-05	0.000233	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GNA11—melanoma	1.08e-05	0.000232	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP17A1—melanoma	1.07e-05	0.000232	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CDKN2B—melanoma	1.07e-05	0.000231	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP17A1—melanoma	1.06e-05	0.00023	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—SLC5A5—melanoma	1.06e-05	0.000229	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.05e-05	0.000228	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—FASN—melanoma	1.05e-05	0.000227	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.05e-05	0.000226	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CD86—melanoma	1.04e-05	0.000224	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—CXCL8—melanoma	1.04e-05	0.000224	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	1.04e-05	0.000224	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—SLC5A5—melanoma	1.04e-05	0.000223	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—EDN1—melanoma	1.03e-05	0.000222	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GNAQ—melanoma	1.02e-05	0.000221	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CD44—melanoma	1.02e-05	0.000221	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GNA11—melanoma	1.01e-05	0.000219	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CSF2—melanoma	1e-05	0.000217	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FGF1—melanoma	1e-05	0.000217	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GNA11—melanoma	1e-05	0.000217	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1e-05	0.000216	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GNAQ—melanoma	1e-05	0.000216	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CD44—melanoma	1e-05	0.000216	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.94e-06	0.000214	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—FASN—melanoma	9.92e-06	0.000214	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—IL2—melanoma	9.9e-06	0.000214	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—E2F1—melanoma	9.83e-06	0.000212	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—FASN—melanoma	9.83e-06	0.000212	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP1B1—melanoma	9.82e-06	0.000212	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PIK3CB—melanoma	9.79e-06	0.000211	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—SLC5A5—melanoma	9.76e-06	0.000211	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PDGFRA—melanoma	9.73e-06	0.00021	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	9.71e-06	0.00021	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—SLC5A5—melanoma	9.67e-06	0.000209	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PRKCA—melanoma	9.63e-06	0.000208	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ITGB3—melanoma	9.63e-06	0.000208	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP1B1—melanoma	9.59e-06	0.000207	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SPP1—melanoma	9.45e-06	0.000204	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GNAQ—melanoma	9.42e-06	0.000203	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CD44—melanoma	9.42e-06	0.000203	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MAP2K2—melanoma	9.42e-06	0.000203	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—CXCL8—melanoma	9.41e-06	0.000203	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CD44—melanoma	9.34e-06	0.000202	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GNAQ—melanoma	9.34e-06	0.000202	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PLA2G6—melanoma	9.26e-06	0.0002	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	9.15e-06	0.000197	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.06e-06	0.000196	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ABCB1—melanoma	9.06e-06	0.000196	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP1B1—melanoma	9.03e-06	0.000195	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—IL2—melanoma	8.99e-06	0.000194	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TERT—melanoma	8.96e-06	0.000193	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP1B1—melanoma	8.95e-06	0.000193	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—RAC1—melanoma	8.93e-06	0.000193	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.67e-06	0.000187	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HIF1A—melanoma	8.57e-06	0.000185	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PRKCA—melanoma	8.34e-06	0.00018	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—VCAN—melanoma	8.32e-06	0.000179	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ERCC2—melanoma	8.27e-06	0.000178	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—KDR—melanoma	8.19e-06	0.000177	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ABCB1—melanoma	8.09e-06	0.000175	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.9e-06	0.000171	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FN1—melanoma	7.89e-06	0.00017	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NOTCH1—melanoma	7.72e-06	0.000167	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CD80—melanoma	7.56e-06	0.000163	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—APC—melanoma	7.55e-06	0.000163	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CG—melanoma	7.55e-06	0.000163	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—KIT—melanoma	7.55e-06	0.000163	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—NRAS—melanoma	7.55e-06	0.000163	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—EGF—melanoma	7.46e-06	0.000161	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PRKCA—melanoma	7.44e-06	0.000161	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ABCB1—melanoma	7.44e-06	0.000161	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ERCC2—melanoma	7.38e-06	0.000159	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ABCB1—melanoma	7.37e-06	0.000159	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PRKCA—melanoma	7.26e-06	0.000157	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—MAPK3—melanoma	7.23e-06	0.000156	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ERCC2—melanoma	7.2e-06	0.000155	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—BRAF—melanoma	7.09e-06	0.000153	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP17A1—melanoma	7.02e-06	0.000151	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IGF1—melanoma	6.91e-06	0.000149	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—MAPK1—melanoma	6.88e-06	0.000148	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—EGFR—melanoma	6.88e-06	0.000148	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.85e-06	0.000148	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PRKCA—melanoma	6.85e-06	0.000148	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ERCC2—melanoma	6.79e-06	0.000147	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PRKCA—melanoma	6.79e-06	0.000146	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ERCC2—melanoma	6.73e-06	0.000145	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MAP2K1—melanoma	6.68e-06	0.000144	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CD—melanoma	6.63e-06	0.000143	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GNA11—melanoma	6.63e-06	0.000143	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—PIK3CA—melanoma	6.57e-06	0.000142	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CG—melanoma	6.53e-06	0.000141	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—KRAS—melanoma	6.5e-06	0.00014	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—FASN—melanoma	6.48e-06	0.00014	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SLC5A5—melanoma	6.38e-06	0.000138	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FGF2—melanoma	6.35e-06	0.000137	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PPARG—melanoma	6.3e-06	0.000136	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GNAQ—melanoma	6.16e-06	0.000133	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CD44—melanoma	6.16e-06	0.000133	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.11e-06	0.000132	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PIK3CA—melanoma	5.97e-06	0.000129	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MDM2—melanoma	5.94e-06	0.000128	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP1B1—melanoma	5.91e-06	0.000127	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ERBB2—melanoma	5.86e-06	0.000126	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CG—melanoma	5.83e-06	0.000126	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CB—melanoma	5.78e-06	0.000125	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CD—melanoma	5.74e-06	0.000124	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CG—melanoma	5.69e-06	0.000123	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ALB—melanoma	5.67e-06	0.000122	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PPARG—melanoma	5.63e-06	0.000121	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.58e-06	0.00012	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CXCL8—melanoma	5.56e-06	0.00012	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—HRAS—melanoma	5.52e-06	0.000119	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PPARG—melanoma	5.49e-06	0.000119	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CDKN1B—melanoma	5.43e-06	0.000117	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—AKT1—melanoma	5.37e-06	0.000116	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CG—melanoma	5.36e-06	0.000116	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CASP3—melanoma	5.32e-06	0.000115	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CG—melanoma	5.32e-06	0.000115	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IL2—melanoma	5.31e-06	0.000115	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—IL6—melanoma	5.28e-06	0.000114	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CCND1—melanoma	5.18e-06	0.000112	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PPARG—melanoma	5.17e-06	0.000112	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PPARG—melanoma	5.13e-06	0.000111	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CTNNB1—melanoma	5.13e-06	0.000111	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CD—melanoma	5.12e-06	0.000111	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ALB—melanoma	5.06e-06	0.000109	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MMP9—melanoma	5.03e-06	0.000108	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CDKN1A—melanoma	5.01e-06	0.000108	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CB—melanoma	5e-06	0.000108	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CD—melanoma	5e-06	0.000108	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PTEN—melanoma	5e-06	0.000108	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NFKB1—melanoma	4.97e-06	0.000107	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PTGS2—melanoma	4.96e-06	0.000107	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ALB—melanoma	4.94e-06	0.000107	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—AKT1—melanoma	4.87e-06	0.000105	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ABCB1—melanoma	4.86e-06	0.000105	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CD—melanoma	4.71e-06	0.000102	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CD—melanoma	4.67e-06	0.000101	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ALB—melanoma	4.65e-06	0.0001	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ALB—melanoma	4.61e-06	9.96e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—VEGFA—melanoma	4.51e-06	9.74e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PRKCA—melanoma	4.48e-06	9.66e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—STAT3—melanoma	4.47e-06	9.64e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CB—melanoma	4.47e-06	9.64e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NRAS—melanoma	4.46e-06	9.62e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ERCC2—melanoma	4.44e-06	9.58e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PTGS2—melanoma	4.43e-06	9.55e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CB—melanoma	4.36e-06	9.41e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PTEN—melanoma	4.32e-06	9.33e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PTGS2—melanoma	4.32e-06	9.32e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MAPK3—melanoma	4.27e-06	9.21e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MYC—melanoma	4.15e-06	8.96e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CB—melanoma	4.11e-06	8.87e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CB—melanoma	4.07e-06	8.79e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PTGS2—melanoma	4.07e-06	8.79e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MAPK1—melanoma	4.06e-06	8.77e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—EGFR—melanoma	4.06e-06	8.77e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PTGS2—melanoma	4.04e-06	8.71e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PTEN—melanoma	3.86e-06	8.33e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—KRAS—melanoma	3.84e-06	8.28e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PTEN—melanoma	3.77e-06	8.13e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PTEN—melanoma	3.55e-06	7.66e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CA—melanoma	3.53e-06	7.61e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PTEN—melanoma	3.52e-06	7.6e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CG—melanoma	3.51e-06	7.57e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TP53—melanoma	3.41e-06	7.36e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PPARG—melanoma	3.38e-06	7.3e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HRAS—melanoma	3.26e-06	7.04e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IL6—melanoma	3.12e-06	6.74e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CD—melanoma	3.08e-06	6.65e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CA—melanoma	3.05e-06	6.58e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ALB—melanoma	3.04e-06	6.57e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—AKT1—melanoma	2.88e-06	6.22e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CA—melanoma	2.72e-06	5.88e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CB—melanoma	2.69e-06	5.8e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PTGS2—melanoma	2.66e-06	5.74e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CA—melanoma	2.66e-06	5.74e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CA—melanoma	2.5e-06	5.41e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—AKT1—melanoma	2.49e-06	5.38e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CA—melanoma	2.48e-06	5.36e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PTEN—melanoma	2.32e-06	5.01e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—AKT1—melanoma	2.22e-06	4.8e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—AKT1—melanoma	2.17e-06	4.69e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—AKT1—melanoma	2.05e-06	4.42e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—AKT1—melanoma	2.03e-06	4.38e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CA—melanoma	1.64e-06	3.53e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—AKT1—melanoma	1.34e-06	2.89e-05	CbGpPWpGaD
